Pfizer (PFE) Assets (2009 - 2026)

Pfizer (PFE) has 18 years of Assets data on file, last reported at $208.0 billion in Q1 2026.

• Quarterly Assets changed 0.01% year-over-year to $208.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208.0 billion (changed 0.01% YoY) and the FY2025 annual result came in at $208.2 billion, down 2.45% from the prior year.
• Assets held at $208.0 billion in Q1 2026 per PFE's latest filing, from $208.2 billion in the prior quarter.
• Across five years, Assets topped out at $226.5 billion in Q4 2023 and bottomed at $41.1 billion in Q4 2022.
• The 5-year median for Assets is $208.2 billion (2025), against an average of $199.1 billion.
• The widest annual swing landed in 2022, when Assets dropped 11.22%; it then soared 422.64% in 2023.
• Tracing PFE's Assets over 5 years: stood at $197.0 billion in 2022, then advanced by 14.98% to $226.5 billion in 2023, then slipped by 5.79% to $213.4 billion in 2024, then declined by 2.45% to $208.2 billion in 2025, then retreated by 0.08% to $208.0 billion in 2026.
• Per Business Quant, the three latest PFE Assets figures stand at $208.0 billion (Q1 2026), $208.2 billion (Q4 2025), and $209.0 billion (Q3 2025).

Peer Comparison